| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.11B | 39.13B | 31.14B | 29.88B | 29.49B | 32.88B |
| Gross Profit | 37.11B | 33.68B | 29.75B | 29.74B | 29.34B | 32.67B |
| EBITDA | 3.90B | -26.18B | 8.22B | 5.92B | 6.55B | 4.85B |
| Net Income | 5.76B | -24.46B | 4.52B | 3.53B | 4.09B | 1.75B |
Balance Sheet | ||||||
| Total Assets | 2.40T | 2.42T | 2.38T | 2.41T | 2.39T | 2.57T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 282.49B | 167.71B | 195.49B | 188.35B | 376.58B |
| Total Debt | 125.19B | 140.30B | 121.49B | 120.39B | 115.89B | 292.99B |
| Total Liabilities | 2.30T | 2.33T | 2.29T | 2.29T | 2.27T | 2.44T |
| Stockholders Equity | 92.06B | 90.00B | 90.64B | 118.07B | 117.16B | 124.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.15B | 0.00 | -1.61B | -211.22B | 3.50B |
| Operating Cash Flow | 0.00 | 6.98B | 0.00 | 941.00M | -209.39B | 5.00B |
| Investing Cash Flow | 0.00 | 73.12B | 6.16B | 7.42B | 22.39B | -10.91B |
| Financing Cash Flow | 0.00 | 31.86B | -15.21B | -1.12B | -169.78B | -1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥26.77B | 9.65 | ― | 3.50% | 1.03% | 12.15% | |
70 Outperform | ¥44.24B | 10.24 | ― | 3.28% | 17.02% | 10.99% | |
68 Neutral | ¥50.34B | 7.54 | ― | 1.20% | 30.84% | 60.48% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥28.96B | 14.07 | ― | 2.59% | 17.44% | 9.26% | |
59 Neutral | ¥17.13B | 14.62 | ― | 3.37% | 6.15% | -0.87% | |
58 Neutral | ¥45.44B | -1.87 | ― | 2.87% | 26.62% | -660.86% |